Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Health & wellness/
  4. Walk this way! How 5-minute strolls at work can boost your mood and cut cravings
Get moving at work Lede image

Walk this way! How 5-minute strolls at work can boost your mood and cut cravings

The research has become impossible to ignore: All this sitting we’re doing is doing us in. And while we know staying glued to our office chairs is bad for our health (and our mindset), what’s the alternative? Turns out, it’s pretty simple.

A recent study supported by Johnson & Johnson found that when people integrated short bursts of walking into a 6-hour day of simulated office work, they felt more energized than when they simply took bathroom breaks.

The best part for those of us short on time: taking just a 5-minute stroll each hour in the workday boosted mood, countered fatigue and cut food cravings more than a single 30-minute exercise session.

“Boosting mood and energy doesn’t require a major time commitment; this research proves that a few tweaks to your daily routine can impact and improve well-being,” says
Jennifer Turgiss, DrPH, Vice President, Behavioral Science and Analytics, Johnson & Johnson Health and Wellness Solutions.

So go ahead: Make a totally doable New Year’s resolution to get healthier by setting an hourly calendar reminder for 5-minute breaks.

Soon enough, popping out of your chair may just become second nature.

More from Johnson & Johnson

6 ways Johnson & Johnson is using AI to help advance healthcare

Artificial intelligence is revolutionizing healthcare—from improving surgical training and procedures to equipping healthcare providers with insights and personalizing care for patients around the world. See how the company is harnessing its extraordinary power.

How Johnson & Johnson is advancing the fight against Alzheimer’s disease

After decades of commitment to understanding this neurodegenerative disease, company scientists have developed innovative therapies and tools that can potentially slow its progression and ease the psychological toll on patients and caretakers. A cure is still elusive—but preventing the disease may be within reach.

Is this the end of one-size-fits-all treatments for depression?

Learn how Johnson & Johnson is working to better address the needs of the 7 in 10 people with depression whose treatments aren’t providing enough relief.